The drug ABIPIP contains
one active pharmaceutical ingredient (API):
UNII 82VFR53I78 - ARIPIPRAZOLE
It has been proposed that aripiprazole’s efficacy in schizophrenia and Bipolar I Disorder is mediated through a combination of partial agonism at dopamine D2 and serotonin 5-HT1A receptors and antagonism of serotonin 5-HT2A receptors.
Read about Aripiprazole
This drug has been classified in the anatomical therapeutic chemical (ATC) classification
system as follows: